Literature DB >> 11035748

Characterization of the catalytic domain of Clostridium novyi alpha-toxin.

C Busch1, K Schömig, F Hofmann, K Aktories.   

Abstract

Clostridium novyi alpha-toxin belongs to the family of large clostridial cytotoxins which act on cells through the modification of small GTP-binding proteins. We present here an analysis of the catalytic domain of alpha-toxin. A NH(2)-terminal 551-amino-acid fragment, alpha 551, was found to contain the full enzyme activity of the holotoxin, whereas a slightly shortened fragment encompassing 509 amino acids showed no detectable enzyme activity. Further characterization of the enzymatically active fragment alpha 551 revealed a substrate specificity for both UDP-N-acetylglucosamine and UDP-glucose. A Michaelis-Menten constant of 17 microM was determined for the substrate UDP-N-acetylglucosamine, while that for UDP-glucose was about 20 times higher, indicating a weaker affinity of the toxin for the latter substrate. Mutation of the aspartic acids of a conserved motif DXD within alpha 551 reduced enzyme activity >700-fold and inhibited cytotoxicity after microinjection in cells. Inhibition of enzyme activity of the DXD mutant could be partially overcome by increased concentrations of manganese ions, suggesting the involvement of these aspartic acids in Mn(2+) binding. By construction of chimeras of enzymatically active fragments of C. sordellii lethal toxin and C. novyi alpha-toxin, we located the region involved in nucleotide-sugar specificity to amino acids 133 through 517.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035748      PMCID: PMC97722          DOI: 10.1128/IAI.68.11.6378-6383.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

Review 1.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 2.  Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins.

Authors:  C von Eichel-Streiber; P Boquet; M Sauerborn; M Thelestam
Journal:  Trends Microbiol       Date:  1996-10       Impact factor: 17.079

3.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.

Authors:  R M Horton; H D Hunt; S N Ho; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

4.  Crystal structures of the bovine beta4galactosyltransferase catalytic domain and its complex with uridine diphosphogalactose.

Authors:  L N Gastinel; C Cambillau; Y Bourne
Journal:  EMBO J       Date:  1999-07-01       Impact factor: 11.598

5.  Structure of the nucleotide-diphospho-sugar transferase, SpsA from Bacillus subtilis, in native and nucleotide-complexed forms.

Authors:  S J Charnock; G J Davies
Journal:  Biochemistry       Date:  1999-05-18       Impact factor: 3.162

6.  Involvement of a conserved tryptophan residue in the UDP-glucose binding of large clostridial cytotoxin glycosyltransferases.

Authors:  C Busch; F Hofmann; R Gerhard; K Aktories
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

7.  Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin.

Authors:  F Hofmann; C Busch; U Prepens; I Just; K Aktories
Journal:  J Biol Chem       Date:  1997-04-25       Impact factor: 5.157

8.  A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C. difficile toxin B and C. sordellii lethal toxin.

Authors:  P Bette; A Oksche; F Mauler; C von Eichel-Streiber; M R Popoff; E Habermann
Journal:  Toxicon       Date:  1991       Impact factor: 3.033

9.  Pharmacological and biochemical studies of cytotoxicity of Clostridium novyi type A alpha-toxin.

Authors:  P Bette; J Frevert; F Mauler; N Suttorp; E Habermann
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

10.  A common motif of eukaryotic glycosyltransferases is essential for the enzyme activity of large clostridial cytotoxins.

Authors:  C Busch; F Hofmann; J Selzer; S Munro; D Jeckel; K Aktories
Journal:  J Biol Chem       Date:  1998-07-31       Impact factor: 5.157

View more
  6 in total

1.  EhRho1, a RhoA-like GTPase of Entamoeba histolytica, is modified by clostridial glucosylating cytotoxins.

Authors:  Shubhra Majumder; Gudula Schmidt; Anuradha Lohia; Klaus Aktories
Journal:  Appl Environ Microbiol       Date:  2006-10-20       Impact factor: 4.792

2.  Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo.

Authors:  Jan-Michael A Klapproth; Maiko Sasaki; Melanie Sherman; Brian Babbin; Michael S Donnenberg; Paula J Fernandes; Isabel C A Scaletsky; Daniel Kalman; Asma Nusrat; Ifor R Williams
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives.

Authors:  Glen P Carter; Julian I Rood; Dena Lyras
Journal:  Gut Microbes       Date:  2010-01

Review 4.  Vaccine Production to Protect Animals Against Pathogenic Clostridia.

Authors:  Nicolas E Zaragoza; Camila A Orellana; Glenn A Moonen; George Moutafis; Esteban Marcellin
Journal:  Toxins (Basel)       Date:  2019-09-11       Impact factor: 4.546

5.  Inhibition of O-GlcNAcylation protects from Shiga toxin-mediated cell injury and lethality in host.

Authors:  Kyung-Soo Lee; Jieun Lee; Pureum Lee; Bong Chan Jeon; Min Yeong Song; Sojung Kwak; Jungwoon Lee; Jun-Seob Kim; Doo-Jin Kim; Ji Hyung Kim; Vernon L Tesh; Moo-Seung Lee; Sung-Kyun Park
Journal:  EMBO Mol Med       Date:  2021-11-29       Impact factor: 12.137

6.  Clostridiumnovyi's Alpha-Toxin Changes Proteome and Phosphoproteome of HEp-2 Cells.

Authors:  Theresa Schweitzer; Harald Genth; Andreas Pich
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.